Cleared Traditional

K192642 - 308nm Excimer System

K192642 is an FDA 510(k) clearance for 308nm Excimer System, manufactured by Chongqing Peninsula Medical Technology Co., Ltd.. The device is a Class 2 General & Plastic Surgery device with product code FTC cleared through the Traditional 510(k) pathway after a 232-day FDA review.

K192642 · Chongqing Peninsula Medical Technology Co., Ltd. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2020
Decision
232d
Days
Class 2
Risk

K192642 is an FDA 510(k) clearance for the 308nm Excimer System. Classified as Light, Ultraviolet, Dermatological (product code FTC), Class II - Special Controls.

Submitted by Chongqing Peninsula Medical Technology Co., Ltd. (Chongqing, CN). The FDA issued a Cleared decision on May 13, 2020 after a review of 232 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4630 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Chongqing Peninsula Medical Technology Co., Ltd. devices

FDA 510(k) Submission Details - K192642

510(k) Number K192642 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 24, 2019
Decision Date May 13, 2020
Days to Decision 232 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
117d slower than avg
Panel avg: 115d · This submission: 232d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FTC Device Classification - Class 2, Special Controls

Product Code FTC Light, Ultraviolet, Dermatological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Consultant

Guangzhou Glomed Biologcial Technology Co., Ltd.
Cassie Lee

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - FTC Light, Ultraviolet, Dermatological

All 68
Devices cleared under the same product code (FTC) and FDA review panel - the closest regulatory comparables to K192642.
308nm Excimer System
K200971 · Xuzhou Kernel Medical Equipment Co., Ltd. · Dec 2020
308nm Excimer UV-light Skin Therapy System
K202827 · Shenzhen Gsd Tech Co., Ltd. · Dec 2020
Psoria-Shield AURORA
K192411 · Psoria-Shield · Jul 2020
UV Radiation Treatment System
K191571 · Xuzhou Yongkang Electronic Science Technology Co., Ltd. · Feb 2020
Exciplex
K191086 · Clarteis · Dec 2019
UV Phototherapy
K181805 · Xuzhou Kernel Medical Equipment Co., Ltd. · Jan 2019